Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S.  International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

As a partner at Axinn, Rachel Adcox is the go-to for clients facing high-stakes litigation or billion-dollar negotiations. A consistent standout in antitrust, Rachel delivers results by skillfully navigating complex civil litigation and managing concurrent civil and criminal actions at both state and federal levels.

Brooke Oppenheimer’s practice focuses on discovery, cybersecurity, and data protection. Brooke regularly advises clients on general discovery litigation strategy, data management, privacy, security compliance, and breach response. Further, Brooke manages large document review projects and productions in preparation for depositions, expert discovery, and trial.

Having previously served as in-house competition counsel for both Google and Lyft, Drew’s expertise is in providing clients practical, concise, and business-savvy antitrust advice so that clients can focus on what is most important – their business – while minimizing antitrust risk. Drew has advised clients (including internal c-suite executives) on a wide variety of antitrust issues that span Section 1 and 2 of the Sherman Act, including: developing competitive intelligence policies, participating in industry associations (including benchmarking and Noerr-Pennington petitioning conduct), refusals to deal, competitor partnerships, M&A due diligence, investor relations calls (signaling risk), bundled discounting and other pricing practices, product design changes, and proper information sharing practices. Drew has also designed and implemented company-wide antitrust compliance policies and trained thousands of business stakeholders on proper antitrust practices.

Kail Jethmalani represents clients across industries in all areas of antitrust law, including high-stakes litigation, domestic and cross-border mergers, and investigations.

Nicholas Duffee is an associate in Axinn’s Litigation group. His practice focuses on complex litigation. Currently, he is on the team representing Alvogen in the multibillion dollar National Prescription Opiate multidistrict litigation and in related proceedings across the country, and the team representing Aetna in an appeal before the Federal Circuit. He has regularly advised clients on their potential liability exposure in contract disputes and on their own potential causes of action. Nicholas also has an active pro bono practice representing indigent litigants in federal court and advising nonprofits on copyright issues.

Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S.  International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

As a partner at Axinn, Rachel Adcox is the go-to for clients facing high-stakes litigation or billion-dollar negotiations. A consistent standout in antitrust, Rachel delivers results by skillfully navigating complex civil litigation and managing concurrent civil and criminal actions at both state and federal levels.